Back
Adaptimmune Therapeutics PLC Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
15
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.24
Seasonality Move:
-0.05%
7 Day Trial
ALL ACCESS PASS
$
7
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.25 | Buy |
| 20-day SMA: | 0.27 | Sell |
| 50-day SMA: | 0.27 | Sell |
| 200-day SMA: | 0.56 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.26 | Sell |
| 50-day EMA: | 0.29 | Sell |
| 200-day EMA: | 0.53 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42.72 | Sell |
| Chaikin Money Flow: | 265782 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.25 - 0.29) | Sell |
| Bollinger Bands (100): | (0.22 - 0.5) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.25 while ADAP 8-day simple moving average is 0.25, which is a Buy signal.
-
The stock price of ADAP is 0.25 while Adaptimmune Therapeutics PLC 20-day SMA is 0.27, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day simple moving average is 0.27 while ADAP share price is 0.25, making it a Sell technically.
-
ADAP stock price is 0.25 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.56, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
15
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a SellThe current Adaptimmune Therapeutics PLC [ADAP] share price is $0.25. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
67.1M
Price in USD:
0.25
Share Volume:
463.7K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
1.48
52-Week Low:
0.20
Sell
15
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?The Adaptimmune Therapeutics PLC stock price is 0.25 USD today.
-
Will ADAP stock go up or go down?Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptimmune Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.25 while ADAP 8-day exponential moving average is 0.25, which is a Sell signal.
-
The stock price of ADAP is 0.25 while Adaptimmune Therapeutics PLC 20-day EMA is 0.26, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.29 while ADAP share price is 0.25, making it a Sell technically.
-
ADAP stock price is 0.25 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.53, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and an increase next year of $0.01 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
-
ADAP Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Adaptimmune Therapeutics PLC is a Sell
-
Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 42.72, which suggest Adaptimmune Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.25 - 0.29), which suggest Adaptimmune Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.22 - 0.5), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.